ÎÚÑ»´«Ã½

President Biden testing positive for COVID-19 again days after completing a course of Paxlovid has raised the question of whether the length of the antiviral treatment should be reconsidered.
 

Some experts think it might be worth getting a second booster now if you face a high risk of COVID-19 exposure or if your previous dose was ages ago. The rise of BA.5 has spooked many of them, despite evidence the virus causes less severe disease now than at any other point during the pandemic.
 

The designation will free up emergency funds and lift some bureaucratic hurdles, but many experts fear containment may no longer be possible.
 

While the BA.5 variant of COVID-19—the most transmissible version of the virus to date—spreads quickly around the country, many school and district leaders plan to start the 2022-23 school year with fewer pandemic precautions in place.
 

Most Americans who died of COVID-19 were immunocompromised or older than 75, experts said. These patients ranged in vaccination status – from being unvaccinated to receiving all their recommended vaccines and boosters.
 

Four fatalities from the escalating global monkeypox outbreak have been confirmed since last week: two in Spain, one in India, and one in Brazil, according to public health authorities in those countries. Should U.S. clinicians start worrying? Not yet, according to public health experts.
 

The new booster shot could be a game changer in the fight against COVID-19. The booster, designed to target the omicron variants, is expected to be approved as soon as September.
 

Testing has since expanded to around 80,000 tests per week, after five large commercial laboratories partnered with the federal government to boost the nation’s testing efforts. But while the ability to run more tests has improved, there are still barriers that prevent people from accessing them.
 

More than 2½ years into the pandemic, and with a highly contagious version of the virus circulating, the CDC guidelines for what to do when falling ill — and when to return to public life — continue to stoke as much confusion as clarity.
 

As the third winter of the coronavirus pandemic looms in the northern hemisphere, scientists are warning weary governments and populations alike to brace for more waves of COVID-19.
 

As the first wave of the COVID pandemic devastated the U.S., hospitals looked to the nation's stockpile for desperately needed supplies. They weren't there. 
 

The U.S. Centers for Disease Control has found that that while fatal overdoses rose dramatically during the first year of the coronavirus pandemic across all racial demographics, overdose fatalities surged especially among Black and Native American individuals.